New Study Shows COVID-19 Breakthroughs Don't Affect HIV Immune Status

A recent study from the CIVET-II cohort brings reassuring news for people living with HIV (PWH).

Researchers evaluated how COVID-19 breakthrough infections affect CD4 T-cell counts—a key indicator of immune health—in vaccinated individuals.

The findings indicate that while breakthrough infections can occur, they do not lead to a long-term or clinically significant decline in CD4 counts.

Although minor fluctuations may happen immediately after infection, data shows a consistent rebound in immune cells within two months, confirming the immune system's ability to recover.

However, this study also highlights the importance of ongoing clinical caution.

Research consistently shows that individuals with HIV are more susceptible to contracting breakthrough COVID-19 infections than the general population.

Furthermore, those with lower CD4 counts face a higher risk of severe illness if infected.

Therefore, medical experts continue to emphasize that, while the virus may not permanently damage the immune status of treated patients, vaccination remains the most critical defense.

Staying up-to-date with vaccine doses is essential for PWH to prevent severe disease and hospitalization, balancing the reality of increased infection risk with the proven efficacy of modern medical interventions.